Bibliography

2011

Hillier SM, Kern AM, Maresca KP, Marquis JC, Eckelman WC, Joyal JL, Babich JW.  [123I] MIP-1072, a Small-Molecule Inhibitor of Prostate-Specific Membrane Antigen, Is Effective at Monitoring Tumor Response to Taxane Therapy. 
Journal of Nuclear Medicine 2011 52:1087-1093 (10.2967/jnumed.110.086751)
or online at: http://jnm.snmjournals.org

2010

Bushnell, Jr., DL, O’Dorisio TM, O’Dorisio MS, Menda Y, Hicks RJ, Van Cutsem E, Baulieu JL, Borson-Chazot F, Anthony, Lowell, Benson AB, Oberg K, Grossman AB, Connolly M, Bouterfa, H, Li Yong, Kacena, K, LaFrance, N, Pauwels, SA. 
90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide. Journal of Clinical Oncology. 2010 April 1 (published online 2010 March).

Kontos MC, Dilsizian V, Weiland F, DePuey G, Mahmarian JJ, Iskandrian AE, Bateman, TM, Heller GV, Ananthasubramaniam K, Li Y, Goldman JL, Armor T, Kacena  KA, LaFrance, ND, Garcia EV, Babich JW, Udelson JE. Iodofiltic Acid I 123 (BMIPP) Fatty Acid Imaging Improves Initial Diagnosis in Emergency Department Patients With Suspected Acute Coronary Syndromes: A Multicenter Trial. Journal of the American College of Cardiology 2010 July 20.

2009

Hillier SM, Maresca KP, Femia FJ, Marquis JC, Foss CA, Nguyen N, Zimmerman CN, Barrett JA, Eckelman WC, Pomper MG, Joyal JL, Babich JW. Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues that Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer. Cancer Research, 2009 Sep 1; 69(17): 6932-40.

Maresca KP, Hillier SM, Femia FJ, Zimmerman CN, Levadala MK, Banerjee SR, Hicks J, Sundararajan C, Valliant J, Zubieta J, Eckelman WC, Joyal JL, Babich JW. Comprehensive Radiolabeling, Stability, and Tissue Distribution Studies of Technetium-99m Single Amino Acid Chelates (SAAC). Bioconjug Chem. 2009 Jul 2; 20 (8): 1625–1633.

2008

McCluskey AG, Boyd M, Pimlott SL, Babich JW, Gaze MN, Mairs RJ. Experimental treatment of neuroblastoma using [131I]meta-iodobenzylguanidine and topotecan in combination. Br J Radiol. 2008 Oct;81 Spec No 1:S28-35.

Armstrong AF, Oakley N, Parker S, Causey PW, Lemon J, Capretta A, Zimmerman C, Joyal J, Appoh F, Zubieta J, Babich JW, Singh G, Valliant JF. A robust strategy for the preparation of libraries of metallopeptides. A new paradigm for the discovery of targeted molecular imaging and therapy agents. Chem Commun (Camb). 2008 Nov 21;(43):5532-4. Epub 2008 Sep 24.

Barrett JA, Mairs R, Boyd M, Stubbs JB, McDonald J, Joyal J, Hillier S, Babich JW. 131I-MIP-1145 a novel targeted radiotherapeutic for the treatment of metastatic melanoma. European Journal of Nucl Med and Med Imaging 2008 35:suppl 2 s160.

Barrett JA, Anderson T, Hillier S, Irwin D, Norenberg JP, Stubbs JB, Stabin MG, Joyal J, Kacena K, Babich JW. Determination of the ability of 111In-Onalta (edotreotide) to be used as an imaging surrogate for the accurate prediction of 90Y Onalta radiation absorbed dose. J Nucl Med 2008 49: suppl 1: 333.

Barrett JA, Coleman RE, Morse MA , Kronauge JF, Stubbs JB, Mok H, Qi J, Petry NA, Vaidyanathan G, Babich JW. Carrier added 131I-MIBG (Ultratrace iobenguane I 131) in 7 carcinoid and 4 pheochromocytoma patients. Br J of Hypertension 2008

Eckleman WC, Coleman RE, Langen, KJ. Nuclear Medicine and Biology, Radiopharmaceutical Sciences, Vol. 35, Suppl. 1 pp.S1-1-S1:92 ISSN 0969 8051 2008 August

Femia FJ, Maresca KP, Hillier SM, Zimmerman CN, Joyal JL, Barrett JA, Aras O, Dilsizian V, Eckelman WC, Babich JW. Synthesis and evaluation of a series of 99mTc(CO)3+ lisinopril complexes for in vivo imaging of angiotensin-converting enzyme expression. J Nucl Med. 2008 Jun;49(6):970-7. Epub 2008 May 15.

Stephenson KA, Reid LC, Zubieta J, Babich JW, Kung MP, Kung HF, Valliant JF. Synthesis and screening of a library of Re/Tc-based amyloid probes derived from beta-breaker peptides. Bioconjug Chem. 2008 May;19(5):1087-94. Epub 2008 Apr 12.

2007

Barrett JA, Coleman RE , Mairs R, Joyal J, Morse MA , Kronauge J, Stubbs JB, Mok H, Qi J Petry N, Vaidyanathan S, Babich JW. Preclinical pharmacology and radiation dosimetry and clearance of no carrier added 131I-mIBG (UltratraceTM Iobenguane I 131) J Nucl Med 2007

Pastore CJ, Babich JW, Udelson JE. Future directions of myocardial fatty acid imaging. J Nucl Cardiol. 2007 May-Jun;14(3 Suppl):S153-63.

Eckelman WC, Babich JW. Synthesis and validation of fatty acid analogs radiolabeled by nonisotopic substitution. J Nucl Cardiol. 2007 May-Jun;14(3 Suppl):S100-9.

Schaffer P, Gleave JA, Lemon JA, Reid LC, Pacey LK, Farncombe TH, Boreham DR, Zubieta J, Babich JW, Doering LC, Valliant JF. Isostructural fluorescent and radioactive probes for monitoring neural stem and progenitor cell transplants. Nucl Med Biol. 2008
Feb;35(2):159-69.

2006

James S, Maresca KP, Babich JW, Valliant JF, Doering L, Zubieta J. Isostructural re and 99mTc complexes of biotin derivatives for fluorescence and radioimaging studies. Bioconjug Chem. 2006 May-Jun;17(3):590-6.

James S, Maresca KP, Allis DG, Valliant JF, Eckelman W, Babich JW, Zubieta J. Extension of the single amino acid chelate concept (SAAC) to bifunctional biotin analogues for complexation of the M(CO)3(+1) Core (M = Tc and Re): syntheses, characterization, biotinidase stability, and avidin binding. Bioconjug Chem. 2006 May-Jun;17(3):579-89.

Wei L, Babich JW, Ouellette W, Zubieta J. Developing the {M(CO)3}+ core for fluorescence applications: Rhenium tricarbonyl core complexes with benzimidazole, quinoline, and tryptophan derivatives. Inorg Chem. 2006 Apr 3;45(7):3057-66.

Donovan A, Forbes J, Dorff P, Schaffer P, Babich J, Valliant JF. A new strategy for preparing molecular imaging and therapy agents using fluorine-rich (fluorous) soluble supports. J Am Chem Soc. 2006 Mar 22;128(11):3536-7.